logo-loader

Compound selection for brain cancer therapy 'a significant milestone' for Midatech

Published: 15:01 22 May 2017 BST

Jim Phillips, chief executive of Midatech Pharma Plc (LON:MTPH NASDAQ:MTP) tells Proactive they've selected their preferred compound candidate for testing as a potential therapy for glioblastoma (GBM), a rare form of brain cancer.

Caledonia Mining tackles 2023 challenges with optimism for 2024 as it...

Caledonia Mining Corporation PLC (AIM:CMCL, NYSE-A:CMCL) chief executive Mark Learmonth tells Proactive's Stephen Gunnion the company faced a challenging 2023, primarily due to poor production in the first half of the year at its core asset, the Blanket Mine in Zimbabwe, and an underperformance...

1 hour, 25 minutes ago